reprinted from Issue 14, Spring 2012 of Frontiers of Medicine (PDF)
$proxy_page= "/news/fom.html"; ?>
Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease (ILD), a group of more than 200 conditions that cause scarring (called fibrosis) or inflammation of the lungs. The most common symptoms of IPF are shortness of breath and a persistent dry, hacking cough. It is estimated that about 100,000 people in the U.S. are affected by IPF. The cause of IPF is still unknown, and there is not yet a cure.
The UCSF Interstitial Lung Disease Program, directed by Harold R. Collard, MD, is one of the few centers nation-wide specializing in the treatment of lung scarring. The program brings together the expertise of pulmonologists, radiologists, pathologists and nurses who specialize in treating patients with IPF and other forms of ILD. In addition, the ILD Program hosts educational seminars and runs a monthly patient support group called Living Well with ILD. The program also conducts novel research into the biology and epidemiology of IPF and other forms of ILD.
See related story: Harroun Family Foundation - Great Loss Inspires Search for IPF Cure.